Revolutionizing Healthcare with Early Disease Detection
Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
Doctors in Taiwan made a surprising discovery when a 64-year-old female patient complained of a clicking and rustling sound in her ear, which turned out to be a spider.
Many DNA tests on the market offer a glimpse into what makes your individual character, including who your ancestors are and some can even analyze your risk for developing certain diseases. Cheddar News spoke with Sam Beeler, chief strategy officer with Nebula Genomics; Eleanor Griffith, a certified genetic counselor; and Dr. Neil Iyengar, a medical oncologist with Memorial Sloan Kettering Cancer Center about the process involved in checking DNA and its effectiveness.
